https://www.selleckchem.com/pr....oducts/Aloxistatin.h
Data will be extracted and assessed, with aggregate data being reported. When the data allow, meta-analysis will be performed. There are no ethical concerns with this systematic review, as data have previously been published. This review will inform clinicians taking care of children with OSA and obesity/metabolic syndrome about the potential effects of NIV therapies on metabolic markers and has the potential to change the approach to childhood OSA and obesity. Results of this systematic review will be submitted for dissemination in
Like
Comment
Share
